274 related articles for article (PubMed ID: 20065507)
1. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet.
Kuda O; Stankova B; Tvrzicka E; Hensler M; Jelenik T; Rossmeisl M; Flachs P; Kopecky J
J Physiol Pharmacol; 2009 Dec; 60(4):135-40. PubMed ID: 20065507
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone increases fatty acid Δ9-desaturation and decreases elongase activity index in human skeletal muscle in vivo.
Mai K; Andres J; Bobbert T; Assmann A; Biedasek K; Diederich S; Graham I; Larson TR; Pfeiffer AF; Spranger J
Metabolism; 2012 Jan; 61(1):108-16. PubMed ID: 21741058
[TBL] [Abstract][Full Text] [Related]
4. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
[TBL] [Abstract][Full Text] [Related]
5. n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet.
Kuda O; Jelenik T; Jilkova Z; Flachs P; Rossmeisl M; Hensler M; Kazdova L; Ogston N; Baranowski M; Gorski J; Janovska P; Kus V; Polak J; Mohamed-Ali V; Burcelin R; Cinti S; Bryhn M; Kopecky J
Diabetologia; 2009 May; 52(5):941-51. PubMed ID: 19277604
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
7. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
Dobrzyń A; Dobrzyń P
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.
Lessard SJ; Rivas DA; Chen ZP; Bonen A; Febbraio MA; Reeder DW; Kemp BE; Yaspelkis BB; Hawley JA
Diabetes; 2007 Jul; 56(7):1856-64. PubMed ID: 17440174
[TBL] [Abstract][Full Text] [Related]
9. Corn oil versus lard: Metabolic effects of omega-3 fatty acids in mice fed obesogenic diets with different fatty acid composition.
Pavlisova J; Bardova K; Stankova B; Tvrzicka E; Kopecky J; Rossmeisl M
Biochimie; 2016 May; 124():150-162. PubMed ID: 26151346
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of metabolic effects of rosiglitazone.
Seda O; Sedová L; Oliyarnyk O; Kazdová L; Krenová D; Corbeil G; Hamet P; Tremblay J; Kren V
Pharmacogenomics; 2008 Feb; 9(2):141-55. PubMed ID: 18370844
[TBL] [Abstract][Full Text] [Related]
11. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance.
Todd MK; Watt MJ; Le J; Hevener AL; Turcotte LP
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E485-93. PubMed ID: 17003244
[TBL] [Abstract][Full Text] [Related]
13. Long-term dietary supplementation with saury oil attenuates metabolic abnormalities in mice fed a high-fat diet: combined beneficial effect of omega-3 fatty acids and long-chain monounsaturated fatty acids.
Yang ZH; Inoue S; Taniguchi Y; Miyahara H; Iwasaki Y; Takeo J; Sakaue H; Nakaya Y
Lipids Health Dis; 2015 Dec; 14():155. PubMed ID: 26627187
[TBL] [Abstract][Full Text] [Related]
14. Insulin sensitivity is not associated with palmitoleate availability in obese humans.
Fabbrini E; Magkos F; Su X; Abumrad NA; Nejedly N; Coughlin CC; Okunade AL; Patterson BW; Klein S
J Lipid Res; 2011 Apr; 52(4):808-12. PubMed ID: 21266364
[TBL] [Abstract][Full Text] [Related]
15. Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin.
Ye JM; Dzamko N; Cleasby ME; Hegarty BD; Furler SM; Cooney GJ; Kraegen EW
Diabetologia; 2004 Jul; 47(7):1306-1313. PubMed ID: 15232684
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
Singh Ahuja H; Liu S; Crombie DL; Boehm M; Leibowitz MD; Heyman RA; Depre C; Nagy L; Tontonoz P; Davies PJ
Mol Pharmacol; 2001 Apr; 59(4):765-73. PubMed ID: 11259621
[TBL] [Abstract][Full Text] [Related]
17. Dietary cholesterol opposes PUFA-mediated repression of the stearoyl-CoA desaturase-1 gene by SREBP-1 independent mechanism.
Kim HJ; Miyazaki M; Ntambi JM
J Lipid Res; 2002 Oct; 43(10):1750-7. PubMed ID: 12364560
[TBL] [Abstract][Full Text] [Related]
18. Trans-10,cis-12-CLA-caused lipodystrophy is associated with profound changes of fatty acid profiles of liver, white adipose tissue and erythrocytes in mice: possible link to tissue-specific alterations of fatty acid desaturation.
Jaudszus A; Moeckel P; Hamelmann E; Jahreis G
Ann Nutr Metab; 2010; 57(2):103-11. PubMed ID: 20924169
[TBL] [Abstract][Full Text] [Related]
19. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet.
Silbernagel G; Kovarova M; Cegan A; Machann J; Schick F; Lehmann R; Häring HU; Stefan N; Schleicher E; Fritsche A; Peter A
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2288-92. PubMed ID: 23015656
[TBL] [Abstract][Full Text] [Related]
20. Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet.
Kus V; Flachs P; Kuda O; Bardova K; Janovska P; Svobodova M; Jilkova ZM; Rossmeisl M; Wang-Sattler R; Yu Z; Illig T; Kopecky J
PLoS One; 2011; 6(11):e27126. PubMed ID: 22073272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
